Raw data from clinical trials: Within reach?

Peter Doshi; Steven N. Goodman; John P A Ioannidis

doi:10.1016/j.tips.2013.10.006

Raw data from clinical trials: Within reach?

Peter Doshi, Steven N. Goodman, John P A Ioannidis

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Abstract

Making raw data from clinical trials widely publically available should reduce selective reporting biases and enhance the reproducibility of and trust in clinical research. The optimal procedures for data sharing are hotly debated. Some of the caveats and limitations in proposed data-sharing policies are potentially restrictive, and we argue in favor of more widespread availability of data from clinical research.

Original language	English (US)
Pages (from-to)	645-647
Number of pages	3
Journal	Trends in Pharmacological Sciences
Volume	34
Issue number	12
DOIs	https://doi.org/10.1016/j.tips.2013.10.006
State	Published - Dec 2013
Externally published	Yes

ASJC Scopus subject areas

Pharmacology
Toxicology

Access to Document

10.1016/j.tips.2013.10.006

Cite this

@article{8a910531edb5419b9b9657a31d1f26fc,

title = "Raw data from clinical trials: Within reach?",

abstract = "Making raw data from clinical trials widely publically available should reduce selective reporting biases and enhance the reproducibility of and trust in clinical research. The optimal procedures for data sharing are hotly debated. Some of the caveats and limitations in proposed data-sharing policies are potentially restrictive, and we argue in favor of more widespread availability of data from clinical research.",

author = "Peter Doshi and Goodman, {Steven N.} and Ioannidis, {John P A}",

year = "2013",

month = dec,

doi = "10.1016/j.tips.2013.10.006",

language = "English (US)",

volume = "34",

pages = "645--647",

journal = "Trends in Pharmacological Sciences",

issn = "0165-6147",

publisher = "Elsevier Ltd",

number = "12",

}

TY - JOUR

T1 - Raw data from clinical trials

T2 - Within reach?

AU - Doshi, Peter

AU - Goodman, Steven N.

AU - Ioannidis, John P A

PY - 2013/12

Y1 - 2013/12

N2 - Making raw data from clinical trials widely publically available should reduce selective reporting biases and enhance the reproducibility of and trust in clinical research. The optimal procedures for data sharing are hotly debated. Some of the caveats and limitations in proposed data-sharing policies are potentially restrictive, and we argue in favor of more widespread availability of data from clinical research.

AB - Making raw data from clinical trials widely publically available should reduce selective reporting biases and enhance the reproducibility of and trust in clinical research. The optimal procedures for data sharing are hotly debated. Some of the caveats and limitations in proposed data-sharing policies are potentially restrictive, and we argue in favor of more widespread availability of data from clinical research.

UR - http://www.scopus.com/inward/record.url?scp=84889076911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889076911&partnerID=8YFLogxK

U2 - 10.1016/j.tips.2013.10.006

DO - 10.1016/j.tips.2013.10.006

M3 - Article

C2 - 24295825

AN - SCOPUS:84889076911

SN - 0165-6147

VL - 34

SP - 645

EP - 647

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

IS - 12

ER -

Raw data from clinical trials: Within reach?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this